Gilead Sciences (GILD) PT Lowered to $69 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Matthew Harrison lowered the price target on Gilead Sciences (NASDAQ: GILD) to $69.00 (from $72.00) after 4Q ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
